Severe paroxysmal hypertension (pseudopheochromocytoma)
- PMID: 18367021
- DOI: 10.1007/s11906-008-0005-2
Severe paroxysmal hypertension (pseudopheochromocytoma)
Abstract
Paroxysmal hypertension always engenders a search for a catecholamine-secreting pheochromocytoma. Yet 98% of people with paroxysmal hypertension do not have this tumor. The cause and management of paroxysmal hypertension remain a mystery, and the subject of remarkably few papers. This review presents an approach to understanding and successfully treating this disorder. Patients experience symptomatic blood pressure surges likely linked to sympathetic nervous system stimulation. A specific personality profile associated with this disorder suggests a psychological basis, attributable to repressed emotion related to prior emotional trauma or a repressive (nonemotional) coping style. Based on this understanding, three forms of intervention, alone or in combination, appear successful: antihypertensive therapy with agents directed at the sympathetically mediated blood pressure elevation (eg, combined alpha- and beta-blockade or central alpha-agonists such as clonidine); psychopharmacologic interventions including anxiolytic and/or antidepressant agents; and psychological intervention, particularly reassurance and increased psychological awareness. An appropriately selected intervention can reduce or eliminate attacks in most patients.
Similar articles
-
Pseudopheochromocytoma.Endocrinol Metab Clin North Am. 2019 Dec;48(4):751-764. doi: 10.1016/j.ecl.2019.08.004. Epub 2019 Sep 18. Endocrinol Metab Clin North Am. 2019. PMID: 31655774 Free PMC article. Review.
-
Catecholamine excess: pseudopheochromocytoma and beyond.Adv Chronic Kidney Dis. 2015 May;22(3):218-23. doi: 10.1053/j.ackd.2014.11.002. Adv Chronic Kidney Dis. 2015. PMID: 25908471 Review.
-
Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment.Arch Intern Med. 1999 Apr 12;159(7):670-4. doi: 10.1001/archinte.159.7.670. Arch Intern Med. 1999. PMID: 10218745 Review.
-
Clarifying the Cause and Treatment of Paroxysmal Hypertension (Pseudopheochromocytoma).Curr Hypertens Rep. 2022 Sep;24(9):353-359. doi: 10.1007/s11906-022-01198-1. Epub 2022 Jun 6. Curr Hypertens Rep. 2022. PMID: 35666406 Review.
-
Unexplained symptomatic paroxysmal hypertension in pseudopheochromocytoma: a stress response disorder?Ann N Y Acad Sci. 2008 Dec;1148:469-78. doi: 10.1196/annals.1410.019. Ann N Y Acad Sci. 2008. PMID: 19120143
Cited by
-
Lateralizing sensorimotor deficits in a case of pseudopheochromocytoma.Yale J Biol Med. 2014 Dec 12;87(4):569-73. eCollection 2014 Dec. Yale J Biol Med. 2014. PMID: 25506289 Free PMC article.
-
Correction of carotid artery stenosis by stent placement ameliorated paroxysmal hypertension after radiation treatment of hypopharyngeal carcinoma: a case report.J Med Case Rep. 2022 Feb 17;16(1):70. doi: 10.1186/s13256-022-03293-y. J Med Case Rep. 2022. PMID: 35172903 Free PMC article.
-
Pseudopheochromocytoma: An uncommon cause of malignant hypertension.Indian J Nephrol. 2009 Jul;19(3):122-4. doi: 10.4103/0971-4065.57111. Indian J Nephrol. 2009. PMID: 20436734 Free PMC article.
-
Central sympatholytics prolong survival in experimental sepsis.Crit Care. 2009;13(1):R11. doi: 10.1186/cc7709. Epub 2009 Feb 6. Crit Care. 2009. PMID: 19196475 Free PMC article.
-
Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge.J Gen Intern Med. 2020 Feb;35(2):586-589. doi: 10.1007/s11606-019-05503-8. Epub 2019 Nov 8. J Gen Intern Med. 2020. PMID: 31705462 Free PMC article. No abstract available.